Boston Scientific Corporation  

(Public, NYSE:BSX)   Watch this stock  
17.51
+0.40 (2.34%)
After Hours: 17.68 +0.17 (0.95%)
Jul 28, 6:38PM EDT  
NYSE real-time data - Disclaimer
Currency in USD
Range 16.96 - 17.51
52 week 11.10 - 18.62
Open 17.20
Vol / Avg. 0.00/9.10M
Mkt cap 22.94B
P/E     -
Div/yield     -
EPS -0.12
Shares 1.34B
Beta 1.06
Inst. own 92%
Oct 20, 2015
Q3 2015 Boston Scientific Corp Earnings Release (Estimated) - 9:30AM EDT - Add to calendar
Aug 5, 2015
Boston Scientific Corp at CFA Society of Minnesota's InvestMNt Conference - 11:55AM EDT - Add to calendar
Jul 23, 2015
Q2 2015 Boston Scientific Corp Earnings Release
Jul 23, 2015
Q2 2015 Boston Scientific Corp Earnings Call - Webcast
Jun 9, 2015
Boston Scientific Corp at Goldman Sachs Healthcare Conference
May 12, 2015
Boston Scientific Corp at Bank of America Merrill Lynch Health Care Conference
May 6, 2015
Boston Scientific Corp at Deutsche Bank Health Care Conference
May 5, 2015
Boston Scientific Corp Annual Shareholders Meeting
May 1, 2015
Boston Scientific Corp Investor Day Business Review - Webcast
More events from DailyFinance »    

Key stats and ratios

Q2 (Jun '15) 2014
Net profit margin 5.53% -1.61%
Operating margin 11.88% -4.08%
EBITD margin - 22.70%
Return on average assets 2.44% -0.71%
Return on average equity 6.26% -1.83%
Employees 24,000 -
CDP Score - 46

Address

300 BOSTON SCIENTIFIC WAY
MARLBOROUGH, MA 01752-1234
United States - Map
+1-508-6834000 (Phone)
+1-508-6508923 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
About Company - Wikipedia

Description

Boston Scientific Corporation develops, manufactures and markets medical devices. The Company offers its products by seven core businesses: Interventional Cardiology, which includes Drug-Eluting Coronary Stent Systems, Intravascular Imaging devised and Coronary Technology products, such as guide wires, guide catheters, and balloon catheters, among others; Peripheral Interventions (PI), which include stents, balloon catheters, wires, peripheral embolization devices and vena cava filters; Cardiac Rhythm Management (CRM), which include implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities; Electrophysiology (EP), which include steerable RF ablation catheters, intracardiac ultrasound catheters, diagnostic catheters, delivery sheaths, and other accessories; Endoscopy, which includes Spyglass System, WallFlex Colonic Stents, Resolution Clip, and Expect Aspiration Needle, among others; Urology and Women’s Health, and Neuromodulation.

Officers and directors

Peter M. Nicholas Chairman of the Board
Age: 73
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Michael F. Mahoney President, Chief Executive Officer, Director
Age: 50
Bio & Compensation  - Reuters
Joseph M. Fitzgerald Executive Vice President and President - Rhythm Management
Age: 51
Bio & Compensation  - Reuters
Daniel Brennan Chief Financial Officer, Executive Vice President
Age: 49
Bio & Compensation  - Reuters
Timothy A. Pratt Chief Administrative Officer, Executive Vice President, General Counsel, Secretary
Age: 65
Bio & Compensation  - Reuters
Supratim Bose Executive Vice President and President - Asia-Pacific, Middle East and Africa
Age: 62
Bio & Compensation  - Reuters
Keith D. Dawkins M.D. Global Chief Medical Officer, Executive Vice President
Age: 64
Bio & Compensation  - Reuters
Michael P. Phalen Executive Vice President and President - MedSurg
Age: 55
Bio & Compensation  - Reuters
Wendy Carruthers Senior Vice President - Human Resources
Age: 46
Bio & Compensation  - Reuters
Kevin J. Ballinger Senior Vice President and President, Interventional Cardiology
Age: 42
Bio & Compensation  - Reuters